The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationInfliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Self-citationTuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Colombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Self-citationInfliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Self-citationJeffcoate, W. J., & Harding, K. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13169-8 · Cited by 1,050
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Chen, D. M., Pritchard, M. L., & Sandborn, W. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.002 · Cited by 905
Self-citationColombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., Zinsmeister, A. R., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.047 · Cited by 899
Self-citationChemotherapy‐induced neutropenia: Risks, consequences, and new directions for its management
Crawford, J., Dale, D. C., & Lyman, G. H. (2004) · Cancer · doi:10.1002/cncr.11882 · Cited by 882
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Kandiel, A., Fraser, A. G., Korelitz, B. I., Brensinger, C., & Lewis, J. D. (2005) · Gut · doi:10.1136/gut.2004.049460 · Cited by 808
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Colombel, J. F., Loftus, E. V., Tremaine, W. J., Pemberton, J. H., Wolff, B. G., Young-Fadok, T., Harmsen, W. S., Schleck, C. D., & Sandborn, W. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04148.x · Cited by 381
Self-citationAberra, F. N., Lewis, J. D., Hass, D., Rombeau, J. L., Osborne, B., & Lichtenstein, G. R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00883-7 · Cited by 350
Dayharsh, G. A., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Zinsmeister, A. R., Witzig, T. E., Macon, W. R., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.30328 · Cited by 275
Self-citationArts, J., D’Haens, G., Zeegers, M., Van Assche, G., Hiele, M., D’Hoore, A., Penninckx, F., Vermeire, S., & Rutgeerts, P. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00002 · Cited by 227
Winther, K. V., Jess, T., Langholz, E., Munkholm, P., & Binder, V. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.036 · Cited by 209
Incidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease
Gupta, G., Lautenbach, E., & Lewis, J. D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.019 · Cited by 208
Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
Fraser, A. G., Orchard, T. R., Robinson, E. M., & Jewell, D. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01297.x · Cited by 198
Jess, T., Winther, K. V., Munkholm, P., Langholz, E., & Binder, V. (2002) · Gastroenterology · doi:10.1053/gast.2002.33632 · Cited by 191
INFECTIONS ASSOCIATED WITH STEROID USE
Klein, N. C., Go, C. H.-U., & Cunha, B. A. (2001) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70154-9 · Cited by 176
Risk of lymphoma in inflammatory bowel disease
Loftus, E. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01108-4 · Cited by 173
Self-citationThe Role of Bacteria in Exacerbations of COPD
Murphy, T. F., Sethi, S., & Niederman, M. S. (2000) · CHEST Journal · doi:10.1378/chest.118.1.204 · Cited by 116
Safety of Infliximab and Other Biologic Agents in the Inflammatory Bowel Diseases
Reddy, J. G., & Loftus, E. V. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2006.09.008 · Cited by 86
Self-citationManagement of Newly Diagnosed HIV Infection
Hammer, S. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp051203 · Cited by 83
Methods to Avoid Infections in Patients with Inflammatory Bowel Disease
Aberra, F. N., & Lichtenstein, G. R. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160742.91602.b7 · Cited by 64
Guerrant, R. L., Lima, A. Â. M., & Davidson, F. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315924 · Cited by 57
Management of the Febrile Neutropenic Patient: A Consensus Conference
Picazo, J. J. (2004) · Clinical Infectious Diseases · doi:10.1086/383041 · Cited by 37
Common Variable Immunodeficiency: Test Indications and Interpretations
Weiler, C. R., & Bankers‐Fulbright, J. L. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1187 · Cited by 33
Lymphoma risk in inflammatory bowel disease: Influences of referral bias and therapy
Loftus, E. V., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.29271 · Cited by 26
Self-citation
Cited by
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Self-citationLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Self-citationKornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Metadata
- Authors
- Toruner, M., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., Orenstein, R., Sandborn, W. J., Colombel, J., & Egan, L. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 134
- Issue
- 4
- Pages
- 929-936
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2131632358
- Cited by
- 1,017
- References
- 31
- FWCI
- 40.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.